Guohan Hu

1.9k total citations
65 papers, 1.5k citations indexed

About

Guohan Hu is a scholar working on Molecular Biology, Cancer Research and Neurology. According to data from OpenAlex, Guohan Hu has authored 65 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Molecular Biology, 15 papers in Cancer Research and 13 papers in Neurology. Recurrent topics in Guohan Hu's work include Glioma Diagnosis and Treatment (10 papers), Ubiquitin and proteasome pathways (7 papers) and MicroRNA in disease regulation (6 papers). Guohan Hu is often cited by papers focused on Glioma Diagnosis and Treatment (10 papers), Ubiquitin and proteasome pathways (7 papers) and MicroRNA in disease regulation (6 papers). Guohan Hu collaborates with scholars based in China and United States. Guohan Hu's co-authors include Yicheng Lu, Chun Luo, Juxiang Chen, Lei Jiang, Xuehua Ding, Juxiang Chen, Weiqing Li, Lijun Hou, Zheng Cai and Huimin Liu and has published in prestigious journals such as PLoS ONE, Biomaterials and Oncogene.

In The Last Decade

Guohan Hu

63 papers receiving 1.5k citations

Peers

Guohan Hu
Comparison fields: 5 of 97
  • Molecular Biology 987
  • Cancer Research 529
  • Oncology 220
  • Epidemiology 165
  • Neurology 159
Replace Timothy Van Meter with:
Timothy Van Meter United States
Cuiqi Zhou United States
Barbara Banelli Italy
Metka Ravnik‐Glavač Slovenia
Simona Cazacu United States
Kyu‐Sil Choi South Korea
Libo Zhang Canada
Veena Rajaram United States
Yasuo Tohma Japan
Thomas Schwarzmayr Germany
Timothy Van Meter United States View profile →
Citations per field, relative to Guohan Hu
Guohan Hu · 1×
Citations per year, relative to Guohan Hu
Guohan Hu · 1×

Countries citing papers authored by Guohan Hu

Since Specialization
Citations

This map shows the geographic impact of Guohan Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guohan Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guohan Hu more than expected).

Fields of papers citing papers by Guohan Hu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guohan Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guohan Hu. The network helps show where Guohan Hu may publish in the future.

Co-authorship network of co-authors of Guohan Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Guohan Hu. A scholar is included among the top collaborators of Guohan Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guohan Hu. Guohan Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1 0
2 4
3 10
4 2
5 15
6 36
7 24
8 9
9 33
10 16
11 5
12 25
13 42
14 36
15
MicroRNA-328 may contribute to chemoresistance in glioblastoma cancer stem cells by targeting ABCG2
3
16 163
17 12
18 33
19 25
20 4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026